Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2020.08.015 ◽

2021 ◽

Vol 79 (1) ◽

pp. 163-164

Author(s):

David D’Andrea ◽

Benjamin Pradere ◽

Shahrokh F. Shariat

Keyword(s):

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Upper Tract Urothelial Carcinoma ◽

Phase 3 ◽

Upper Tract ◽

Randomised Controlled

Download Full-text

Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2020.04.021 ◽

2020 ◽

Vol 78 (4) ◽

pp. 630-631

Author(s):

Teele Kuusk ◽

Axel Bex

Keyword(s):

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Upper Tract Urothelial Carcinoma ◽

Phase 3 ◽

Upper Tract ◽

Randomised Controlled

Download Full-text

Re: Alison Birtle, Mark Johnson, John Chester, et al. Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. Lancet 2020;395:1268–77

European Urology ◽

10.1016/j.eururo.2020.09.013 ◽

2021 ◽

Vol 79 (1) ◽

pp. e28

Author(s):

Nirmish Singla ◽

Vitaly Margulis

Keyword(s):

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Upper Tract Urothelial Carcinoma ◽

Phase 3 ◽

Upper Tract ◽

Mark Johnson ◽

Randomised Controlled

Download Full-text

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

10.1016/s0140-6736(20)30415-3 ◽

2020 ◽

Vol 395 (10232) ◽

pp. 1268-1277 ◽

Author(s):

Alison Birtle ◽

Mark Johnson ◽

John Chester ◽

Robert Jones ◽

David Dolling ◽

...

Keyword(s):

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Upper Tract Urothelial Carcinoma ◽

Phase 3 ◽

Upper Tract ◽

Randomised Controlled

Download Full-text

Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial

European Urology ◽

10.1016/j.eururo.2020.04.006 ◽

2020 ◽

Vol 78 (2) ◽

pp. 289-290

Author(s):

Luca Afferi ◽

Marco Moschini ◽

Agostino Mattei ◽

Francesco Montorsi ◽

Alberto Briganti ◽

...

Keyword(s):

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Upper Tract Urothelial Carcinoma ◽

Phase 3 ◽

Upper Tract ◽

Randomised Controlled

Download Full-text

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

10.1016/s0140-6736(09)61523-3 ◽

2009 ◽

Vol 374 (9707) ◽

pp. 2055-2063 ◽

Author(s):

Kathy S Albain ◽

William E Barlow ◽

Peter M Ravdin ◽

William B Farrar ◽

Gary V Burton ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Phase 3 ◽

Node Positive ◽

Randomised Controlled ◽

Positive Breast Cancer

Download Full-text

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Yearbook of Oncology ◽

10.1016/s1040-1741(10)79516-6 ◽

2010 ◽

Vol 2010 ◽

pp. 19-21

Author(s):

J.T. Thigpen

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Phase 3 ◽

Node Positive ◽

Randomised Controlled ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732342155.793578099 ◽

2020 ◽

Author(s):

Matthew Milowsky

Keyword(s):

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Locally Advanced ◽

Phase 3 ◽

Open Label Phase ◽

Metastatic Urothelial Carcinoma ◽

Randomised Controlled

Download Full-text

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

10.1016/s0140-6736(17)33297-x ◽

2018 ◽

Vol 391 (10122) ◽

pp. 748-757 ◽

Author(s):

Thomas Powles ◽

Ignacio Durán ◽

Michiel S van der Heijden ◽

Yohann Loriot ◽

Nicholas J Vogelzang ◽

...

Keyword(s):

Randomised Controlled Trial ◽

Urothelial Carcinoma ◽

Controlled Trial ◽

Locally Advanced ◽

Phase 3 ◽

Open Label Phase ◽

Metastatic Urothelial Carcinoma ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Phase 3 ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Phase 3 ◽

D2 Gastrectomy ◽

Randomised Controlled

Download Full-text